Related Experiment Videos
Evaluation of a human hepatoma cell line as a target cell in genetic toxicology
Abstract:
A cell line derived from a human hepatoblastoma, HepG2, was examined for its ability to activate cyclophosphamide (CY) to a genotoxic form. Metabolism of CY to genotoxic product(s) was determined by the induction of sister-chromatid exchanges (SCE). The dose-dependent response pattern in HepG2 was compared to the patterns obtained by three other mammalian cell lines. HepG2 and a rat hepatoma cell line, H4-II-E, show similar dose-dependent increases of induced SCE, whereas non-hepatic-derived fibroblast lines show little or no CY-induced SCE. Microsomal enzyme activities characteristic of cytochromes P450 and P448 and epoxide hydrolase were examined in the two hepatoma cell lines and compared to levels in rat liver microsomal preparations. Although no cultured cell line can be a universal surrogate for in vivo metabolism, we propose that HepG2 may be useful to determine in a qualitative manner whether human cells possess the ability to activate a chemical to a genetically damaging form.
Insights
The HepG2 human cell line can activate cyclophosphamide (CY) into a genotoxic form, indicated by increased sister-chromatid exchanges (SCE). This finding suggests HepG2
Area of Science:
- Hepatocellular carcinoma research
- Genotoxicity testing
- Drug metabolism studies
Background:
- Cyclophosphamide (CY) is a widely used chemotherapy agent.
- Activation of CY into genotoxic metabolites is crucial for its therapeutic and toxic effects.
- Understanding cellular metabolism is key to predicting drug-induced genotoxicity.
Purpose of the Study:
- To evaluate the HepG2 human hepatoblastoma cell line's capacity to metabolize cyclophosphamide (CY) into genotoxic forms.
- To compare the genotoxic response of HepG2 cells to other mammalian cell lines.
- To assess the potential of HepG2 as a model for studying CY-induced genotoxicity in human cells.
Main Methods:
- Assessing genotoxicity by measuring the induction of sister-chromatid exchanges (SCE).
- Comparing dose-dependent SCE induction patterns in HepG2 cells versus other mammalian cell lines (fibroblast lines and a rat hepatoma line).
- Analyzing characteristic microsomal enzyme activities (cytochromes P450, P448, epoxide hydrolase) in hepatoma cell lines and comparing them to rat liver microsomes.
Main Results:
- HepG2 cells demonstrated a dose-dependent increase in CY-induced SCE, similar to the rat hepatoma cell line H4-II-E.
- Non-hepatic-derived fibroblast cell lines showed minimal to no induction of SCE upon CY exposure.
- Microsomal enzyme profiles in HepG2 cells were analyzed and compared to rat liver preparations.
Conclusions:
- The HepG2 cell line effectively activates cyclophosphamide (CY) to genotoxic metabolites, as evidenced by increased SCE.
- HepG2 cells show a comparable metabolic activation capacity for CY to that of the rat hepatoma cell line H4-II-E.
- HepG2 cells represent a valuable in vitro model for qualitatively assessing the potential of chemicals to induce genetic damage in human cells.